Ocular lesions associated with systemic hypertension in dogs: 65 cases (2005–2007)

Abstract

Objective To characterize ocular findings in hypertensive dogs, determine prevalence of hypertension in dogs with ocular disease suggestive of hypertension, and examine possible relationships between degree of hypertension and ocular disease. Design Retrospective case series. Animals 65 dogs initially referred for blood pressure measurement (n = 22), ophthalmic examination (25), or both (18). Procedures Medical records were reviewed to identify dogs examined at the teaching hospital that underwent a complete ophthalmic examination and blood pressure measurement within a 24-hour period between January 1, 2005, and December 31, 2007. Signalment, history, blood pressure measurements, ophthalmic examination findings, and any vasoactive drug treatments were recorded. Ocular lesions considered likely to be associated with systemic hypertension included retinal hemorrhage, retinal detachment, hyphema, tortuous vessels, and subretinal edema. Results Of the 65 dogs, 42 were hypertensive (systolic blood pressure ≥ 160 mm Hg) and 23 were normotensive. Sixty-two percent (26/42) of hypertensive dogs had ≥ 1 type of ocular lesion identified. Retinal hemorrhage was the most common ocular lesion in hypertensive dogs (17/42 [40%]). The presence of ≥ 1 type of ocular lesion had moderate sensitivity and specificity of 62% and 61%, respectively, for identification of hypertension. Fifteen of the 25 (60%) dogs referred for blood pressure measurement after initial ophthalmic examination were found to be hypertensive. Conclusions and Clinical Relevance Ocular lesions are common in dogs with systemic hypertension. Dogs with hypertension or diseases associated with hypertension should be monitored carefully for evidence of ocular target organ damage, and hypertension should be systematically ruled out in dogs with characteristic ocular lesions.

Optical coherence tomography and molecular analysis of sudden acquired retinal degeneration syndrome (SARDS) eyes suggests the immune‐mediated nature of retinal damage

“…Additional studies will be needed to further elucidate the significance of these findings. Considering that proteinuria may result from intermittent systemic hypertension, it cannot be absolutely ruled out that observed perivascular RDs are not the result of intermittent episodes of high blood pressure that may damage the capillary bed, with consequent exudation and retinal detachment, as frequently seen in dogs with systemic hypertension . Retinal funduscopic changes in this study had many features similar to those previously described in monkeys and humans with chronic systemic hypertension .…”

Results of Screening of Apparently Healthy Senior and Geriatric Dogs

“…The most likely explanation for the high prevalence of hypertension is white‐coat hypertension, which is described in dogs, cats, and humans . Indeed, none of the hypertensive dogs had ocular signs of target organ damage, which has been described in 62% of dogs with systemic hypertension . We tried to limit the white‐coat effect by measuring SBP in a quiet environment, after an acclimatization period and with the owner present if possible.…”

“…Bilateral tear production was evaluated with a Schirmer tear test (STT) strip, and a production of ≥15 mm per minute was considered normal . Direct fundoscopy was performed, paying special attention to signs secondary to systemic hypertension, such as retinal hemorrhage or detachment, subretinal edema, or tortuous vessels …”

Intracorneal stromal hemorrhage in dogs and its associations with ocular and systemic disease: 39 cases

“…29,30 Hypertension has a multitude of potential effects on vasculature that increase chances of hemorrhage in different anatomic locations of the canine eye. 31 Systemic hypertension has also been found to frequently be associated with other systemic disease in dogs, including hyperadrenocorticism and diabetes mellitus. 32,33 Five of the six dogs with systemic hypertension in this study had the disease in conjunction with hyperadrenocorticism or diabetes mellitus.…”